William P. Schiemann - Publications

University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 
Pharmacology, Oncology, Cell Biology

61 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Robinson NJ, Morrison-Smith CD, Gooding AJ, Schiemann BJ, Jackson MW, Taylor DJ, Schiemann WP. SLX4IP and telomere dynamics dictate breast cancer metastasis and therapeutic responsiveness. Life Science Alliance. 3. PMID 32071280 DOI: 10.26508/lsa.201900427  0.6
2017 Tian M, Schiemann WP. TGF-β Stimulation of EMT Programs Elicits Non-genomic ER-α Activity and Anti-estrogen Resistance in Breast Cancer Cells. Journal of Cancer Metastasis and Treatment. 3: 150-160. PMID 28955730 DOI: 10.20517/2394-4722.2017.38  0.52
2016 Morrison CD, Allington TM, Thompson CL, Gilmore HL, Chang JC, Keri RA, Schiemann WP. c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expression. Oncotarget. PMID 27626309 DOI: 10.18632/oncotarget.11909  1
2016 Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE. Transforming Growth Factor-β Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. The American Journal of Pathology. PMID 26988652 DOI: 10.1016/j.ajpath.2016.01.008  1
2015 Janyasupab M, Lee YH, Zhang Y, Liu CW, Cai J, Popa A, Samia AC, Wang KW, Xu J, Hu CC, Wendt MK, Schiemann BJ, Thompson CL, Yen Y, Schiemann WP, et al. Detection of Lysyl Oxidase-Like 2 (LOXL2), a Biomarker of Metastasis from Breast Cancers Using Human Blood Samples. Recent Patents On Biomarkers. 5: 93-100. PMID 28670509 DOI: 10.2174/2210309005666150804195033  0.6
2015 Thomas DG, Yenepalli A, Denais CM, Rape A, Beach JR, Wang YL, Schiemann WP, Baskaran H, Lammerding J, Egelhoff TT. Non-muscle myosin IIB is critical for nuclear translocation during 3D invasion. The Journal of Cell Biology. PMID 26261182 DOI: 10.1083/jcb.201502039  1
2015 Correa D, Somoza RA, Lin P, Schiemann WP, Caplan AI. Mesenchymal Stem Cells regulate Melanoma Cancer Cells extravasation to bone and liver at their perivascular niche. International Journal of Cancer. Journal International Du Cancer. PMID 26235173 DOI: 10.1002/ijc.29709  1
2015 Peiris PM, Deb P, Doolittle E, Doron G, Goldberg A, Govender P, Shah S, Rao S, Carbone S, Cotey T, Sylvestre M, Singh S, Schiemann WP, Lee Z, Karathanasis E. Vascular Targeting of a Gold Nanoparticle to Breast Cancer Metastasis. Journal of Pharmaceutical Sciences. 104: 2600-10. PMID 26036431 DOI: 10.1002/jps.24518  1
2015 Parvani JG, Gujrati MD, Mack MA, Schiemann WP, Lu ZR. Silencing β3 Integrin by Targeted ECO/siRNA Nanoparticles Inhibits EMT and Metastasis of Triple-Negative Breast Cancer. Cancer Research. 75: 2316-25. PMID 25858145 DOI: 10.1158/0008-5472.CAN-14-3485  1
2015 Parvani JG, Davuluri G, Wendt MK, Espinosa C, Tian M, Danielpour D, Sossey-Alaoui K, Schiemann WP. Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression. Neoplasia (New York, N.Y.). 17: 317-28. PMID 25810016 DOI: 10.1016/j.neo.2015.02.003  1
2015 Wendt MK, Williams WK, Pascuzzi PE, Balanis NG, Schiemann BJ, Carlin CR, Schiemann WP. The antitumorigenic function of EGFR in metastatic breast cancer is regulated by expression of Mig6. Neoplasia (New York, N.Y.). 17: 124-33. PMID 25622905 DOI: 10.1016/j.neo.2014.11.009  1
2014 Wendt MK, Balanis N, Carlin CR, Schiemann WP. STAT3 and epithelial-mesenchymal transitions in carcinomas. Jak-Stat. 3: e28975. PMID 24843831 DOI: 10.4161/jkst.28975  0.48
2014 Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP. Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers. Breast Cancer Research : Bcr. 16: R24. PMID 24618085 DOI: 10.1186/bcr3623  1
2014 Peiris PM, Toy R, Abramowski A, Vicente P, Tucci S, Bauer L, Mayer A, Tam M, Doolittle E, Pansky J, Tran E, Lin D, Schiemann WP, Ghaghada KB, Griswold MA, et al. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. Journal of Controlled Release : Official Journal of the Controlled Release Society. 173: 51-8. PMID 24188960 DOI: 10.1016/j.jconrel.2013.10.031  1
2013 Wendt MK, Schiemann WP. Longitudinal Bioluminescent Quantification of Three Dimensional Cell Growth. Bio-Protocol. 3. PMID 27453906  0.48
2013 Taylor MA, Davuluri G, Parvani JG, Schiemann BJ, Wendt MK, Plow EF, Schiemann WP, Sossey-Alaoui K. Upregulated WAVE3 expression is essential for TGF-β-mediated EMT and metastasis of triple-negative breast cancer cells. Breast Cancer Research and Treatment. 142: 341-53. PMID 24197660 DOI: 10.1007/s10549-013-2753-1  0.6
2013 Parvani JG, Galliher-Beckley AJ, Schiemann BJ, Schiemann WP. Targeted inactivation of β1 integrin induces β3 integrin switching, which drives breast cancer metastasis by TGF-β. Molecular Biology of the Cell. 24: 3449-59. PMID 24006485 DOI: 10.1091/mbc.E12-10-0776  0.6
2013 Balanis N, Wendt MK, Schiemann BJ, Wang Z, Schiemann WP, Carlin CR. Epithelial to mesenchymal transition promotes breast cancer progression via a fibronectin-dependent STAT3 signaling pathway. The Journal of Biological Chemistry. 288: 17954-67. PMID 23653350 DOI: 10.1074/jbc.M113.475277  1
2013 Taylor MA, Sossey-Alaoui K, Thompson CL, Danielpour D, Schiemann WP. TGF-β upregulates miR-181a expression to promote breast cancer metastasis. The Journal of Clinical Investigation. 123: 150-63. PMID 23241956 DOI: 10.1172/JCI64946  1
2012 Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms and consequences of TGF-β-induced EMT during cancer progression. Cell and Tissue Research. 347: 85-101. PMID 21691718 DOI: 10.1007/s00441-011-1199-1  0.52
2011 Wendt MK, Molter J, Flask CA, Schiemann WP. In vivo dual substrate bioluminescent imaging. Journal of Visualized Experiments : Jove. PMID 22006228 DOI: 10.3791/3245  0.48
2011 Raju R, Nanjappa V, Balakrishnan L, Radhakrishnan A, Thomas JK, Sharma J, Tian M, Palapetta SM, Subbannayya T, Sekhar NR, Muthusamy B, Goel R, Subbannayya Y, Telikicherla D, Bhattacharjee M, ... ... Schiemann WP, et al. NetSlim: high-confidence curated signaling maps. Database : the Journal of Biological Databases and Curation. 2011: bar032. PMID 21959865 DOI: 10.1093/database/bar032  1
2011 Balanis N, Yoshigi M, Wendt MK, Schiemann WP, Carlin CR. β3 integrin-EGF receptor cross-talk activates p190RhoGAP in mouse mammary gland epithelial cells. Molecular Biology of the Cell. 22: 4288-301. PMID 21937717 DOI: 10.1091/mbc.E10-08-0700  1
2011 Yori JL, Seachrist DD, Johnson E, Lozada KL, Abdul-Karim FW, Chodosh LA, Schiemann WP, Keri RA. Krüppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer. Neoplasia (New York, N.Y.). 13: 601-10. PMID 21750654 DOI: 10.1593/neo.11260  1
2011 Wendt MK, Taylor MA, Schiemann BJ, Schiemann WP. Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer. Molecular Biology of the Cell. 22: 2423-35. PMID 21613543 DOI: 10.1091/mbc.E11-04-0306  0.6
2011 Allington TM, Schiemann WP. The Cain and Abl of epithelial-mesenchymal transition and transforming growth factor-β in mammary epithelial cells. Cells, Tissues, Organs. 193: 98-113. PMID 21051857 DOI: 10.1159/000320163  1
2011 Tian M, Neil JR, Schiemann WP. Transforming growth factor-β and the hallmarks of cancer. Cellular Signalling. 23: 951-62. PMID 20940046 DOI: 10.1016/j.cellsig.2010.10.015  1
2011 Tobi M, Kim M, Zimmer R, Hatfield J, Kam M, Khoury N, Carville A, Lawson MJ, Schiemann WP, Thomas P. Colorectal cancer in the cotton top tamarin (Saguinus oedipus): how do they evade liver metastasis? Digestive Diseases and Sciences. 56: 397-405. PMID 20645001 DOI: 10.1007/s10620-010-1314-2  1
2010 Micalizzi DS, Wang CA, Farabaugh SM, Schiemann WP, Ford HL. Homeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth. Cancer Research. 70: 10371-80. PMID 21056993 DOI: 10.1158/0008-5472.CAN-10-1354  1
2010 Tian M, Schiemann WP. PGE2 receptor EP2 mediates the antagonistic effect of COX-2 on TGF-beta signaling during mammary tumorigenesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 24: 1105-16. PMID 19897661 DOI: 10.1096/fj.09-141341  0.52
2009 Wendt MK, Allington TM, Schiemann WP. Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncology (London, England). 5: 1145-68. PMID 19852727 DOI: 10.2217/fon.09.90  1
2009 Wendt MK, Smith JA, Schiemann WP. p130Cas is required for mammary tumor growth and transforming growth factor-beta-mediated metastasis through regulation of Smad2/3 activity. The Journal of Biological Chemistry. 284: 34145-56. PMID 19822523 DOI: 10.1074/jbc.M109.023614  0.48
2009 Wendt MK, Schiemann WP. Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Research : Bcr. 11: R68. PMID 19740433 DOI: 10.1186/bcr2360  0.48
2009 Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Barón AE, Harrell JC, Horwitz KB, Billheimer D, Heichman KA, Welm AL, Schiemann WP, Ford HL. The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. The Journal of Clinical Investigation. 119: 2678-90. PMID 19726885 DOI: 10.1172/JCI37815  1
2009 Tian M, Schiemann WP. Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer. Translational Oncology. 2: 174-83. PMID 19701502  0.52
2009 Allington TM, Galliher-Beckley AJ, Schiemann WP. Activated Abl kinase inhibits oncogenic transforming growth factor-beta signaling and tumorigenesis in mammary tumors. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 4231-43. PMID 19690215 DOI: 10.1096/fj.09-138412  1
2009 Neil JR, Tian M, Schiemann WP. X-linked inhibitor of apoptosis protein and its E3 ligase activity promote transforming growth factor-{beta}-mediated nuclear factor-{kappa}B activation during breast cancer progression. The Journal of Biological Chemistry. 284: 21209-17. PMID 19531477 DOI: 10.1074/jbc.M109.018374  1
2009 Tian M, Schiemann WP. The TGF-beta paradox in human cancer: an update. Future Oncology (London, England). 5: 259-71. PMID 19284383 DOI: 10.2217/14796694.5.2.259  0.52
2008 Neil JR, Johnson KM, Nemenoff RA, Schiemann WP. Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. Carcinogenesis. 29: 2227-35. PMID 18725385 DOI: 10.1093/carcin/bgn202  1
2008 Lee YH, Albig AR, Regner M, Schiemann BJ, Schiemann WP. Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis. 29: 2243-51. PMID 18713838 DOI: 10.1093/carcin/bgn199  1
2008 Albig AR, Becenti DJ, Roy TG, Schiemann WP. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvascular Research. 76: 7-14. PMID 18417156 DOI: 10.1016/j.mvr.2008.01.001  1
2008 Neil JR, Schiemann WP. Altered TAB1:I kappaB kinase interaction promotes transforming growth factor beta-mediated nuclear factor-kappaB activation during breast cancer progression. Cancer Research. 68: 1462-70. PMID 18316610 DOI: 10.1158/0008-5472.CAN-07-3094  1
2008 Galliher-Beckley AJ, Schiemann WP. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta. Carcinogenesis. 29: 244-51. PMID 18174260 DOI: 10.1093/carcin/bgm245  0.36
2007 Albig AR, Roy TG, Becenti DJ, Schiemann WP. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis. 10: 197-216. PMID 17632767 DOI: 10.1007/s10456-007-9075-z  1
2007 Galliher AJ, Schiemann WP. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Research. 67: 3752-8. PMID 17440088 DOI: 10.1158/0008-5472.CAN-06-3851  1
2006 Galliher AJ, Neil JR, Schiemann WP. Role of transforming growth factor-beta in cancer progression. Future Oncology (London, England). 2: 743-63. PMID 17155901 DOI: 10.2217/14796694.2.6.743  1
2006 Galliher AJ, Schiemann WP. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Research : Bcr. 8: R42. PMID 16859511 DOI: 10.1186/bcr1524  1
2006 Neil JR, Galliher AJ, Schiemann WP. TGF-beta in cancer and other diseases. Future Oncology (London, England). 2: 185-9. PMID 16563087 DOI: 10.2217/14796694.2.2.185  1
2006 Albig AR, Neil JR, Schiemann WP. Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Research. 66: 2621-9. PMID 16510581 DOI: 10.1158/0008-5472.CAN-04-4096  1
2005 Albig AR, Schiemann WP. Fibulin-5 function during tumorigenesis. Future Oncology (London, England). 1: 23-35. PMID 16555973 DOI: 10.1517/14796694.1.1.23  1
2005 Sokol JP, Neil JR, Schiemann BJ, Schiemann WP. The use of cystatin C to inhibit epithelial-mesenchymal transition and morphological transformation stimulated by transforming growth factor-beta. Breast Cancer Research : Bcr. 7: R844-53. PMID 16168131 DOI: 10.1186/bcr1312  1
2005 Albig AR, Schiemann WP. Identification and characterization of regulator of G protein signaling 4 (RGS4) as a novel inhibitor of tubulogenesis: RGS4 inhibits mitogen-activated protein kinases and vascular endothelial growth factor signaling. Molecular Biology of the Cell. 16: 609-25. PMID 15548600 DOI: 10.1091/mbc.E04-06-0479  1
2004 Lemaire R, Korn JH, Schiemann WP, Lafyatis R. Fibulin-2 and fibulin-5 alterations in tsk mice associated with disorganized hypodermal elastic fibers and skin tethering. The Journal of Investigative Dermatology. 123: 1063-9. PMID 15610515 DOI: 10.1111/j.0022-202X.2004.23471.x  1
2004 Albig AR, Schiemann WP. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. Dna and Cell Biology. 23: 367-79. PMID 15231070 DOI: 10.1089/104454904323145254  1
2004 Cosgrove GP, Brown KK, Schiemann WP, Serls AE, Parr JE, Geraci MW, Schwarz MI, Cool CD, Worthen GS. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: A role in aberrant angiogenesis American Journal of Respiratory and Critical Care Medicine. 170: 242-251. PMID 15117744  1
2004 Schiemann WP, Rotzer D, Pfeifer WM, Levi E, Rai KR, Knaus P, Kadin ME. Transforming growth factor-beta (TGF-beta)-resistant B cells from chronic lymphocytic leukemia patients contain recurrent mutations in the signal sequence of the type I TGF-beta receptor. Cancer Detection and Prevention. 28: 57-64. PMID 15041079 DOI: 10.1016/j.cdp.2003.11.001  1
2004 Sokol JP, Schiemann WP. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Molecular Cancer Research : McR. 2: 183-95. PMID 15037657  0.36
2004 Ibarrola N, Kratchmarova I, Nakajima D, Schiemann WP, Moustakas A, Pandey A, Mann M. Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor beta signaling. Bmc Cell Biology. 5: 2. PMID 14728725 DOI: 10.1186/1471-2121-5-2  1
2003 Peri S, Navarro JD, Amanchy R, Kristiansen TZ, Jonnalagadda CK, Surendranath V, Niranjan V, Muthusamy B, Gandhi TK, Gronborg M, Ibarrola N, Deshpande N, Shanker K, Shivashankar HN, Rashmi BP, ... ... Schiemann WP, et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. Genome Research. 13: 2363-71. PMID 14525934 DOI: 10.1101/gr.1680803  1
2003 Schiemann BJ, Neil JR, Schiemann WP. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Molecular Biology of the Cell. 14: 3977-88. PMID 14517312 DOI: 10.1091/mbc.E03-01-0001  1
2002 Schiemann WP, Blobe GC, Kalume DE, Pandey A, Lodish HF. Context-specific effects of fibulin-5 (DANCE/EVEC) on cell proliferation, motility, and invasion. Fibulin-5 is induced by transforming growth factor-beta and affects protein kinase cascades. The Journal of Biological Chemistry. 277: 27367-77. PMID 12021267 DOI: 10.1074/jbc.M200148200  1
Show low-probability matches.